ight and topical steroid use for facial vitiligo

Not Applicable

Completed

• Conditions: symmetrical facial vitiligo patients; excimer; topical steroids; vitiligo; face

• Registration Number: TCTR20200204004
• Lead Sponsor: none

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-07-31
• Study Start: 2020-02-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Non-segmental vitiligo subjects with symmetrically distributed depigmented patches on the same anatomical area of each side of the face

Exclusion Criteria

Participants with history of skin cancer, photosensitivity, Koebner phenomenon on the treated areas, known allergy to mometasone cream, and those who were pregnant or lactation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
repigmentation 12 wk visual assessment

Secondary Outcome Measures

Name	Time	Method
adverse reactions 12 wk observation